Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · HP (HPQ)

HP Inc. adds Gianluca Pettiti to board and expands it to 15 directors

Neutral Impact 2 of 5 leadership Written later

HP Inc. expanded its board from 14 to 15 seats and elected Gianluca Pettiti, Executive Vice President and President of Life Sciences, Diagnostics and Applied at Thermo Fisher Scientific, as an independent director on February 21, 2025. He was also named to the Finance, Investment and Technology Committee and the HR and Compensation Committee, and will receive standard non-employee director pay.

Key points

  • Board size increased from 14 to 15 directors, effective February 21, 2025
  • Pettiti receives an annual cash retainer of $105,000 and an annual equity retainer of $220,000, pro-rated for his first partial year
  • Pettiti joins the Finance, Investment and Technology Committee and HR and Compensation Committee

The filing

CompanyHP (HPQ)
Form8-K, current report
Filed with the SECFeb 21, 2025, 4:15 PM ET
Accession number0000047217-25-000010

Items reported: 5.02 Director / Officer Change5.03 Bylaw / Charter Amendment

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 21, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.